Eliem Therapeutics, Inc.
ELYM
Revenue
0.00
0.000.00%
-Assets
217.19M
▼-5.01M▼-2.26%
3 Months ChangeLiabilities
5.31M
▲1.88M▲55.01%
3 Months ChangeFree Cash Flow
-20.21M
▲392.00k▲1.90%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-06-27
Form 8-K
ID: 0001193125-24-170599
2024-06-26
Form 8-K
ID: 0001193125-24-169077
2024-06-12
Form 8-K
ID: 0001193125-24-159994
2024-05-15
Form 10-Q
ID: 0000950170-24-059995
2024-04-11
Form 8-K
ID: 0001193125-24-092520
2024-03-19
Form 8-K
ID: 0001193125-24-070333
2023-11-14
Form 10-Q
ID: 0000950170-23-063675
2023-08-10
Form 10-Q
ID: 0000950170-23-041303
2023-07-20
Form 8-K
ID: 0001193125-23-190074
2023-05-19
Form 8-K
ID: 0001193125-23-149424